New Delhi, March 27 -- Hyderabad-based pharmaceutical major Dr. Reddys Laboratories Limited (DRL) on Wednesday announced an exclusive partnership with Sanofi Healthcare India Private Limited to promote and distribute Sanofis vaccine brands across the country.

Under this collaboration, established vaccine brands for both paediatric and adult populations, such as Hexaxim, Pentaxim, Tetraxim, Menactra, FluQuadri, Adacel, and Avaxim 80U will be marketed and promoted Dr. Reddys Laboratories in India.

These brands collectively generated approximately Rs 426 crore ($51 million) in sales as of IQVIA MAT February 2024.

Sanofi has stated it will retain ownership, manufacturing, and importation rights for these brands in the country.

M.V. Ramana...